Walgreens, CVS, Meijer’s & Walmart CoQ-10 Class Action Settlement

Class Eligibility

The Class is defined to mean “all persons in the United States who purchased a Lang CoQ-10 Softgel product manufactured by Lang Pharma Nutrition, Inc. (hereafter, “Lang CoQ-10 Softgel”) and sold under store brand labels by CVS, Wal-Mart, Walgreens and Meijer (“the Retailers”), from July 1, 2013 until July 24,2018.

  • Wal-Mart’s Equate Clinical Strength High Absorption CoQ-10 100 mg
  • CVS/Pharmacy Ultra CoQ-10 100 mg
  • CVS/Health Ultra CoQ-10 100 mg
  • CVS/Pharmacy Enhanced Absorption Formula CoQ-10 100 mg
  • CVS/Health Enhanced Absorption Formula CoQ-10 100 mg
  • Walgreens Well at Walgreens CoQ-10 Enhanced Absorption Formula 100 mg
  • Walgreens Well at Walgreens CoQ-10 Enhanced Absorption Formula 200 mg
  • Meijer’s Ultra CoQ-10 100 mg (“Meijer Ultra CoQ-10”)

Estimated Amount

Class Members who file a valid claim form must choose between a partial cash refund of $3.50 pro rata or a product credit valued at $12.50

Proof of Purchase

No

Case Name

William Jackson, et al. v. Lang Pharma Nutrition Inc., et al.,
Case No. 37-2017-00028196-CU-BC-CTL,

Superior Court of California for the County of San Diego

Case Summary

This matter is a continuation of four earlier CoQ-10 cases involving the Retailer defendants (except Meijer). These Prior CoQ-10 Cases involved CoQ-10 products manufactured by Lang Pharma Nutrition, Inc. and sold by the Retailers. The names of the Prior CoQ-10 Cases are: (1) Thamar Santisteban Cortina v. Wal-Mart, Inc. et al., Case No. 13-cv-020540, United States District Court for the Southern District of California; (2) Leo Harris v. CVS Pharmacy, Inc., Case No. 5:13-cv-02329, United States District Court for the Central District of California; (3) Raymond Alvandi v. CVS Pharmacy, Inc., Case No. 2:15-cv-01503, United States District Court for the Central District of California; and (4) Gary Reynolds, et al. v. Walgreens, Inc., Case No. 4:15-cv-00324, United States District Court for the Northern District of California (collectively the “Prior CoQ-10 Cases”).
While litigating the Prior CoQ-10 Cases, the parties engaged in substantial investigations, extensive discovery, motion practice, and intense settlement discussions. The Prior CoQ-10 Cases were dismissed; however, the Cortina court ordered that all discovery conducted in that case could be used by the parties in future CoQ-10 litigation. Subsequent to dismissal, the Prior CoQ-10 Cases were refiled as Jackson et al. v. Lang Pharma Nutrition, Inc. et al.

The proposed settlement class covers the time period of July 1, 2013 to July 24, 2018.

Settlement Pool

$1,306,000

Deadline

09/04/18

Contact



Q10 Settlement

c/o Classaura Class Action Administration

1718 Peachtree St. #1080

Atlanta, GA 30309

1-866-532-6710

Contact@q10settlement.com
Кракен даркнетКракен даркнет blacksprut blacksprut